# Monazite Sand Ore Materials \- DOE NBL Safety Data Sheet

Text extracted from the original PDF. Tables, images, symbols and OCR may differ. Check the original PDF for safety information.

- **Document title:** Monazite Sand Ore Materials \- DOE NBL Safety Data Sheet
- **Publisher:** NBL Program Office, U\.S\. Department of Energy
- **Material:** Monazite Sand / Powdered Monazite Sand
- **CAS number:** 1306\-41\-8; 13454\-71\-2; 14913\-14\-5; 14298\-31\-8; 14298\-32\-9; 14485\-31\-5; 13990\-54\-0; 18433\-48\-2; 14808
- **Product code / grade:** CRM 7\-A; 82Th1448
- **Document type:** SDS
- **Original language:** English
- **Region:** United States
- **Revision date:** 24 June 2020
- **Page count:** 17
- **Original filename:** doe\-nbl\-monazite\-2020\.pdf
- **RESDS page:** https://resds\.com/document/monazite\-sand\-ore\-materials\-doe\-nbl\-en\-2ad8beec7a
- **Original PDF:** https://resds\.com/pdf/monazite\-sand\-ore\-materials\-doe\-nbl\-en\-2ad8beec7a\.pdf
- **Source URL:** https://www\.energy\.gov/nnsa/articles/sds\-monazite\-sand
- **Description:** Collected by RESDS\. Original publisher PDF retained\. Radioactive monazite reference material containing cerium, lanthanum, praseodymium, neodymium and optional yttrium phosphates, with thorium and uranium phosphates and quartz listed in Section 3\. Original 17\-page SDS revised 24 June 2020\. U\.S\. Department of Energy government information; republished with acknowledgement under DOE web policy: https://www\.energy\.gov/web\-policies

## Page 1

```text
               SAFETY DATA SHEET
               MONAZITE SAND ORE MATERIALS

SECTION 1: CHEMICAL PRODUCTS & COMPANY IDENTIFICATION

   NBL Program Office
    U. S. Department of Energy,
    1 Science.gov Way,
    Oak Ridge, TN 37830
    1-240-780-6842

    Emergency Phone Numbers: 1-240-780-6842

    Chemical Name: Monazite Sand/Powdered Monazite Sand

    Other Identifiers: CRM 7-A, 82Th1448

    Use and Restriction: This material is prepared for use as a standard or in inter-
     laboratory comparison programs at analytic laboratories, which routinely handle
     uranium. New Brunswick Laboratory (NBL) expects that recipients of this material are
     in compliance with 29 CFR 1910.1200(h) which requires employers to provide
    employees with effective information and training on hazardous chemicals in their
    work area.

SECTION 2: HAZARDS IDENTIFICATION

     Classifications/Hazards:

   OSHA HAZARDS:   Highly toxic by inhalation. Highly toxic by ingestion.

   TARGET ORGANS: Kidney, liver, lungs, brain.

   GHS Classification:

    Acute toxicity, Oral (Category 3)
    Acute toxicity, Inhalation (Category 3)
    Acute toxicity, Dermal (Category 3)
     Target organ toxicity repeated (Category 2)
     Carcinogenicity (Category 1B)
                                 Page 1 of 17



                                            Revision Date: June 24, 2020
```

## Page 2

```text
Specific target organ toxicity – repeated exposure (Category 2)


GHS Label elements, including precautionary statements

Pictogram:





Signal Word:   Danger

Hazard statements(s)

Fatal if swallowed or inhaled
May cause cancer
May cause damage to organs through prolonged or repeated exposure
Causes skin irritation

Precautionary statements (s)

Obtain special instructions before use
Do not handle until all safety precautions have been read and understood
Do not breath dust/fume/gas/mist/vapors/spray
Wash skin thoroughly after handling
Do not eat, drink, smoke when using this product

Other hazards
Radioactive

NFPA Rating (SCALE 0-4)
Health Hazard:      3
Fire:               2
Reactivity:          1

CERLA Rating (SCALE 0-3)
Health:            3
Fire:              2
Reactivity:         1
Persistence:         3

                             Page 2 of 17



                                      Revision Date: June 24, 2020
```

## Page 3

```text
EMERGENCY OVERVIEW:  Odorless, tasteless, and transparent to white hexagonal
crystals or amorphous powder.

Cancer hazard (may cause lung cancer in humans if inhaled). Risk of cancer depends on
duration and level of exposure. May damage the lungs. May be irritating to skin and eyes.
May affect the heart. May cause blood disorders. May cause convulsions. May affect the
central nervous system. May cause adverse reproductive effects. May cause eye damage.
Do not breathe dust. Do not get in eyes, on skin, or on clothing. Keep container tightly
closed. Wash thoroughly after handling. Use only with adequate ventilation. Handle with
caution.

POTENTIAL HEALTH EFFECTS:

INHALATION:
Short Term Exposure:  May cause coughing.  No information available on significant
adverse effects.

Long Term Effects:  May cause coughing, weight  loss, bloody sputum, difficulty in
breathing, weakness, bluish skin color, lung damage and heart disorders. May also cause
anemia, cataracts and cancer.

SKIN CONTACT:
Short Term Exposure: May cause irritation.

Long Term Effects: No information is available.

EYE CONTACT:
Short Term Exposure: May cause irritation, redness and swelling of the eyes and eye
damage.

Long Term Effects: Same as short-term exposure with increased risk of eye damage due to
scratching of corneas and radiation induced cataracts.

INGESTION:
Short Term Exposure: No information available on significant adverse effects.

Long Term Effects: No information is available.

CARCINOGEN STATUS:

OSHA:    N
                             Page 3 of 17



                                      Revision Date: June 24, 2020
```

## Page 4

```text
    NTP:     Y
    IARC:     Y


SECTION 3: COMPOSITION/INFORMATION ON INGREDIENTS

    Chemical Family: Cerium phosphate mineral sand and powdered cerium phosphate
     mineral sand. Ce(Ce, La, Pr, Nd, Th, Y)PO4

   CAS #: 1306-41-8


     Material           Component            CAS Number         Percent

     Monazite    Ce(Ce, La, Pr, Nd, Th, Y)PO4     1306-41-8       100
     Major Constituents:
                Cerium Phosphate (CePO4)       13454-71-2       45-48%
               Lanthanum Phosphate (LaPO4)    14913-14-5       20-28%
               Praseodymium Phosphate (PrPO4) 14298-31-8       4-6%
              Neodymium Phosphate (NdPO4)   14298-32-9       13-21%
               Thorium Phosphate (Th3(PO4)4)  14485-31-5       0-20%
                 Yttrium Phosphate (YPO4)        13990-54-0       0-10%
               Uranium Phosphate (UPO4)       18433-48-2       0-2%
     Possible Contaminants:
                 Quartz (SiO2)                  14808-60-7      <1%


SECTION 4: FIRST AID MEASURES

   INHALATION: Remove from exposure area to fresh air immediately.  If breathing has
     stopped,  perform  artificial  respiration.   Keep  person warm  and  at  rest.    Treat
     symptomatically and supportively.  Get medical attention immediately. Any evidence of
     contamination indicates  that treatment must be  instituted.   (Inhalation of radioactive
     particles may indicate that other parts of the body were also contaminated, such as the
     digestive tract, skin, and eyes.)  If time permits, wipe the face with wet filter paper, force
    coughing and blowing of the nose. Get medical attention immediately. The victim may be
     contaminated with radioactive particles.  Thorough decontamination should be started
     before the victim is moved to the medical area. Any personnel involved in rendering first
     aid must be monitored for radioactivity and thoroughly decontaminated if necessary.


                                 Page 4 of 17



                                            Revision Date: June 24, 2020
```

## Page 5

```text
    SKIN CONTACT: Remove victim to a suitable area for decontamination as quickly as
     possible. Remove clothing and shoes immediately. Thoroughly wash the victim with soap
    and water, paying particular attention to the head, fingernails and palms of the hands. Upon
     completion of washing, monitor the victim for radioactivity.  It is imperative that the skin
     should be decontaminated as quickly as possible. Minute skin injuries greatly increase the
     danger of isotope penetration into the victim; shaving should not be attempted.  If water and
    soap  have  been  inadequate  in removing  the  radioactive  material,  decontamination
    compounds  consisting  of  surfactants  and  absorbent  substances may  be  effective.
    Complexing reagents may also be of use. The use of organic solvents is to be avoided, as
     they may increase the  solubility and absorption of the radioactive substance.   Skin
     contamination with radiation may be an indication that other parts of the body have been
     exposed.   Contaminated  clothing  must  be  stored  in  a  metal  container  for  later
     decontamination or disposal. The water used to wash the victim must be stored in metal
     containers for later disposal. Any personnel involved in rendering first aid to the victim
    must be monitored for radioactivity and decontaminated if necessary.

   EYE CONTACT: Wash eyes immediately with large amounts of water or normal saline,
     occasionally  lifting  upper and  lower  lids,  until no  evidence  of  chemical  remains
     (approximately 15-20 minutes). Get medical attention immediately. Monitor the victim for
     radioactivity.   If activity is present, rewash the eyes, and remonitor until  little or no
     radioactivity is present. Get medical attention immediately. Any water used to wash the
     victim’s eyes must be stored in a metal container for later disposal. Any other articles that
     are used to decontaminate the victim must also be stored in metal containers for later
     decontamination or disposal. Any personnel involved in rendering first aid to the victim
    must be monitored for radioactivity and decontaminated if necessary.

    INGESTION: In the case of ingestion of radioactive substances, the mouth should be rinsed
     out immediately after the accident. Care should be taken not to swallow the water used for
      this purpose. Vomiting should be induced either mechanically, or with syrup of ipecac. Do
     not induce vomiting in an unconscious person.  Lavage may be useful.  Care should be
     taken to avoid aspiration. The vomitus and lavage fluids should be saved for examination
    and monitoring.  Further action depends on the nature of the radioactive substance. Get
     medical attention immediately. The gastric fluids and fluids used for lavage must be stored
     in metal containers for later disposal. The victim must be monitored for radioactivity and
     decontaminated, if necessary, before being transported to a medical facility. Any personnel
     involved in rendering  first aid to the victim must be monitored for radioactivity and
     decontaminated if necessary.

   NOTE TO PHYSICIAN: Treat symptomatically and supportively.


SECTION 5: FIRE FIGHTING MEASURES
                                 Page 5 of 17



                                            Revision Date: June 24, 2020
```

## Page 6

```text
    FIRE AND EXPLOSION HAZARD:  Negligible fire hazard when exposed to heat or
     flame.

   EXTINGUISHING MEDIA: Dry chemical, carbon dioxide, water spray or regular foam
     (See the most  recent Emergency Response Guidebook (ERG), developed  jointly by
     Transport Canada (TC), the U. S. Department of Transportation (DOT) and the Secretariat
     of Transportation and Communications of Mexico (SCT).)

    For Larger  Fires, use water spray or fog (flooding amounts) (Emergency Response
     Guidebook).

    FIREFIGHTING: Do not move damaged containers; move undamaged containers out of
      fire zone. (Emergency Response Guidebook).

     Contact the local, State, or Department of Energy radiological response team. Use suitable
     agent for surrounding fire. Cool containers with flooding amounts of water, apply from as
      far a distance as  possible.  Avoid breathing dusts or vapors, keep upwind.  Keep
     unnecessary people out of area until declared safe by radiological response team.

   HAZARDOUS COMBUSTION PRODUCTS: Thermal decomposition may release toxic
     and/or hazardous gases.

SECTION 6: ACCIDENTAL RELEASE MEASURES

   OCCUPATIONAL SPILL: Do not touch damaged containers or spilled material. For large
      spills, dike far ahead of spill for later disposal. For dry spills, cover with plastic sheet of
     tarp to minimize spreading.  Keep unnecessary people at least 150 feet upwind of spill.
     Isolate hazard area and deny entry. Limit entry to shortest time possible. Clean up should
    be performed only by qualified radiation worker(s).

   WATER SPILL:  Contaminating any known source of drinking water with substances
    known to cause cancer and/or reproductive toxicity is prohibited by the California Safe
     Drinking Water and Toxic Enforcement Act of 1986 (Proposition 65).


SECTION 7: HANDLING AND STORAGE

    Observe all Federal, State, and local regulations when storing this substance.

     Store in accordance with 10 CFR 20.

                                 Page 6 of 17



                                            Revision Date: June 24, 2020
```

## Page 7

```text
     Store in a designated radioactive materials area.


SECTION 8: EXPOSURE CONTROLS/PERSONAL PROTECTION

   EXPOSURE LIMITS:

   NUISANCE DUST
     5.0   mg/m3 OSHA TWA (total respirable dust as a nuisance dust)

   QUARTZ/CRYSTALLINE SILICA
     10mg/m3 / %SiO2 + 2      mg/m3 OSHA TWA (respirable dust)
      0.02                   mg/m3 ACGIH TWA (respirable dust)
      0.05                   mg/m3 NIOSH recommended TWA (respirable dust)

   YTTRIUM
     1 mg/m3    OSHA/PEL
     1 mg/m3    ACGIH/TLV

   URANIUM
                                           ACGIH
     Uranium in urine = 200 ug/L at end of shift          BIOLOGICAL
                                       EXPOSURE INDEX
      0.2 mg/m3, as U                            TLV ACGIH
      0.6 mg/m3, as U                            STEL ACGIH
      0.05 mg/m3, as U (sol), 0.25 mg/m3, as U (insol)     PEL OSHA
    10 mg/m3, as U                               IDLH NIOSH

     Subject to California Proposition 65 cancer and/or reproductive toxicity warning and release
     requirements - (October 1, 1988)

   EXPOSURE LIMITS:

   THORIUM PHOSPHATE:
    At the time of revision, there are no occupational exposure limits established by OSHA,
    ACGIH, or NIOSH for thorium phosphate.

     Subject to SARA Section 313 Annual Toxic Chemical Release Reporting Subject to
     California  Proposition 65  cancer  and/or  reproductive  toxicity warning and  release
     requirements - (February 27, 1987)

                                 Page 7 of 17



                                            Revision Date: June 24, 2020
```

## Page 8

```text
VENTILATION: At a minimum, provide local exhaust or process enclosure ventilation.
Depending upon the specific workplace activity, a more stringent ventilation system may be
necessary to comply with OSHA exposure limits and those set forth in 10 CFR 20.103.

One method of controlling external radiation exposure is to provide adequate shielding.

ALPHA PARTICLES:  The typical alpha particles emitted by thorium and uranium are
easily shielded by a fraction of a millimeter of any ordinary material or a few inches of air.
Thick paper, plastic, or cardboard will suffice.

BETA PARTICLES: Beta particles are more penetrating than alpha, and require additional
shielding.  These certified reference materials do not emit significant amounts of beta
radiation.

GAMMA RAYS: Gamma rays are highly penetrating and are most easily shielded by
heavier elements (high z number). These certified reference materials, in the quantities used
for laboratory work, do not emit significant amounts of gamma radiation.   If large (kg)
quantities of this material are to be stored or used, consult a radiation protection specialist or
health physicist to determine if shielding is required.

EYE PROTECTION: Employee must wear eye protection to prevent eye contact with this
substance. Contact lenses should not be worn.

Emergency eyewash:  If there is any possibility that an employee's eyes may be exposed to
this substance, the employer must provide an eye wash station within the immediate area for
emergency use.

CLOTHING: Employee must wear impervious clothing to prevent repeated or prolonged
skin contact with this substance.

GLOVES: Employee must wear appropriate protective gloves to prevent contact with this
substance. Used gloves that may have contacted this substance should be disposed of as
radioactive waste.

RESPIRATOR:   The  following  respirators  and maximum  use  concentrations  are
recommendations by the U.S. Department of Health Services, NIOSH Pocket Guide to
Chemical Hazards; or by the U.S. Department of Labor, 29 CFR 1910 Subpart Z.

The specific respirator selected must be based on contamination levels found in the work
place. Airborne contamination levels must not exceed the working limits of the respirator.
Respirators must be jointly approved by the National Institute for Occupational Safety and
Health and the Mine Safety and Health Administration (NIOSH-MSHA).

                             Page 8 of 17



                                      Revision Date: June 24, 2020
```

## Page 9

```text
    SILICA (CRYSTALLINE): At any detectable concentration: Any self-contained breathing
     apparatus with full facepiece, operated in a pressure-demand or other positive pressure
    mode.

    Any supplied-air respirator with a full facepiece and operated in pressure-demand or other
     positive pressure mode in combination with an auxiliary self-contained breathing apparatus
     operated in pressure-demand or other positive pressure mode.

    Escape - Any air-purifying full facepiece respirator with a high-efficiency particulate filter.
    Any appropriate escape-type self-contained breathing apparatus.

   FOR FIREFIGHTING AND OTHER IMMEDIATELY DANGEROUS TO LIFE OR
   HEALTH CONDITIONS:

    Any self-contained breathing apparatus that has a full facepiece and  is operated in a
    pressure-demand or other positive-pressure mode.

    Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or
     other positive-pressure mode in combination with an auxiliary self-contained breathing
     apparatus operated in pressure-demand or other positive-pressure mode.

SECTION 9: PHYSICAL AND CHEMICAL PROPERTIES

    SILICON DIOXIDE
    DESCRIPTION:  Odorless,  tasteless, and  transparent  to white hexagonal  crystals  or
    amorphous powder.
    Molecular weight: 60.09
    Molecular formula: SiO2
     Boiling point: 4046°F (2230°C)
     Melting point: 2930°F (1610°C)
    Vapor Pressure: 0 mmHg @ 20°C
     Specific Gravity: 2.635-2.660
    Water Solubility: insoluble
     Solvent Solubility:  Soluble in hydrofluoric acid; very slightly soluble in alkalis and hot
     concentrated phosphoric acid; insoluble in most acids and organic solvents.

   THORIUM PHOSPHATE
    DESCRIPTION: White, heavy, infusible, crystal, cubes or powder.
    Molecular weight: 264.04
    Molecular formula: Th3(P04)4
     Boiling point: 7952°F (4400°C)
     Melting point: 5738-5918°F (3170-3270°C)
                                 Page 9 of 17



                                            Revision Date: June 24, 2020
```

## Page 10

```text
     Specific Gravity: 9.86
    Water Solubility: insoluble
     Solvent Solubility: Soluble in hot sulfuric acid; insoluble in alkalies and dilute acids.

SECTION 10: STABILITY AND REACTIVITY

    REACTIVITY: Stable under normal temperatures and pressures.

   CONDITIONS TO AVOID: Prevent dispersion of dust in air. Thorium dioxide may burn
     but does not ignite readily.

    INCOMPATIBILITIES:
   QUARTZ:
     Alkalies (Strong): May be attacked.
     Chlorine Trifluoride: Possible explosion.
     Hydrochloric Acid: May be attacked with exothermic reaction.
    Manganese Trifluoride: Violent reaction.
     Metals: May produce violent explosion.
     Oxidizers (Strong): Fire and explosion hazard.
    Oxygen Trifluoride: Possible explosive reaction.
    Ozone: Possible explosive reaction in presence of organic materials.
     Vinyl Acetate: Vigorous reaction
    Xenon Hexafluoride: Possible detonation.

   No data available for incompatibilities of Thorium Phosphate.

   HAZARDOUS DECOMPOSITION:
    Thermal decomposition may release toxic and/or hazardous gases.

   POLYMERIZATION:
    Hazardous polymerization has not been reported to occur under normal temperature and
     pressure.


SECTION 11: TOXICOLOGY INFORMATION

   QUARTZ:
   TOXICITY DATA:  565 million particles/m3/8 hours/17.9 years intermittent inhalation-
    human TCLo; 300 µg/m3/10  years  intermittent  inhalation-human LCLo; 90 mg/kg
     intravenous-rat LDLo; 40 mg/kg intravenous-mouse LDLo; 20 mg/kg intravenous-dog
    LDLo; 200 mg/kg intratracheal-rat LDLo; tumorigenic data (RTECS).

                                 Page 10 of 17



                                            Revision Date: June 24, 2020
```

## Page 11

```text
CARCINOGEN STATUS:   Anticipated Human Carcinogen (NTP); Human Limited
Evidence  Animal  Sufficient  Evidence (IARC  Group-2A).   Adenocarcinomas  and
squamous-cell carcinomas  of  the lung  in  rats  resulted  after  inhalation  or  repeated
intratracheal  instillation of various forms of crystalline  silica.  Malignant lymphomas
developed in rats after intrapleural and intraperitoneal injections of quartz suspensions and
intrapleural injection of cristobalite and tridymite.  Lung cancer occurs more frequently
among silicotics than in the general population.

ACUTE TOXICITY LEVEL: Insufficient data.

TARGET EFFECTS: Poisoning may affect the lungs.

AT INCREASED RISK FOR EXPOSURE: Persons with decreased pulmonary function.

ADDITIONAL DATA:   Cigarette smoking increases the toxic effects by decreasing
pulmonary function.

THORIUM PHOSPHATE:
TOXICITY DATA: Tumorigenic data (RTECS).

CARCINOGEN STATUS: Known Human Carcinogen (NTP).  Intravascular injection in
humans  produced  tumors   of   the   liver,   including   hepatocellular   carcinomas,
cholangiocellular carcinomas, carcinomas of the extra-hepatic biliary system, sarcomas,
hemangioendotheliomas, reticulum cell sarcomas, carcinomas of the common hepatic duct,
adenocarcinomas, liver cell carcinomas, undifferentiated carcinomas, hepatomas, tumors of
the kidney, including carcinomas of the renal parenchyma, and sarcomas and carcinomas of
the renal pelvis.  In addition, carcinomas of the maxillary sinuses. spindle cell sarcomas in
the later cervical region, leukemias, and other hematologic disorders have been related to
intravascular injection of thorium dioxide.  Studies suggest a latency of 21-36 years. A
variety of carcinomas have been induced in animals following intravenous, subcutaneous,
and submucosal administration.

ACUTE TOXICITY LEVEL: No data available.
TARGET EFFECTS: Radioactive

HEALTH EFFECTS
INHALATION
QUARTZ:
CARCINOGEN.

ACUTE EXPOSURE: Exposure to high concentrations may cause physical discomfort of
the upper respiratory tract.
                            Page 11 of 17



                                      Revision Date: June 24, 2020
```

## Page 12

```text
CHRONIC EXPOSURE:   Inhalation  of very high  concentrations  of  finely divided
crystalline silica dust, exposure ranging from a few weeks to 4-5 years, may cause a rapidly
developing silicosis, characterized by pulmonary insufficiency with severe dyspnea, violent
coughing, tachypnea, weight  loss, and cyanosis  leading  to  the development  of cor
pulmonale and death within a relatively short period of time. A slowly developing silicosis
may result from exposure for 6 months-30 years to relatively low levels of the dust. The
first symptom is usually a slowly increasing, non-disabling, exertional dyspnea due to
pulmonary fibrosis and the emphysema associated with  it.  Continued exposure may
increase the rate of progression of the disease.  Also, the fibrogenic action may continue
when exposure ceases. As the fibrosis advances, other symptoms may include shortness of
breath, productive cough, wheezing, chest tightness or pain, marked weakness, decreased
capacity for work, and repeated non-specific chest illnesses.  Cyanosis, clubbing of digits,
orthopnea, or serious weight loss is not usually evident until the disease is advanced.
Pulmonary infections, which may be indicated by hemoptysis, and cardiac decompensation
may exacerbate the symptoms.  Three major complications, which are the most frequent
causes of death, are pulmonary tuberculosis, respiratory insufficiency that is due to the
massive emphysematous and fibrotic changes and is sometimes accompanied by chronic cor
pulmonale, and acute bronchopulmonary infection. A number of studies have shown that
persons diagnosed as having silicosis have an increased risk for dying from lung cancer.
This increase has been seen among miners, quarry workers, foundry workers, ceramic
workers, granite workers, and stone cutters. In some of these studies, the risk of lung cancer
increased with the duration of employment. Various forms and preparations of crystalline
silica produced adenocarcinomas and squamous cell carcinomas of the lungs in rats.

THORIUM PHOSPHATE:
RADIOACTIVE.
Animal exposure to 11-76 mg/m3 of thorium compounds for 2-10 weeks resulted in blood
abnormalities. Inhalation of dusts of radioactive particles may result in permanent deposits
in the lungs and pulmonary lymph nodes.

ALPHA RADIATION
ACUTE EXPOSURE - Alpha radiation is densely ionizing with very high energy.  Cells
immediately adjacent to the source of radiation may be killed or damaged. Damaged cells
may not recover or be repaired.  Thorium dioxide is biologically insoluble.  Insoluble
compounds may remain at or near the site of deposition as opposed to soluble compounds
that may rapidly enter the bloodstream. Heavier particles will be brought up to the throat by
ciliary action, and may then be swallowed.  The lighter particles, typically less than 10
microns in diameter, may enter the gas exchange region of the lungs. These small particles
are what are commonly referred to as the respirable particulate mass. The damage depends
on how quickly they are eliminated, and the susceptibility of the tissue in which they are
stored.

                            Page 12 of 17



                                      Revision Date: June 24, 2020
```

## Page 13

```text
CHRONIC EXPOSURE - The effects of chronic exposure by internally deposited alpha
radiation is dependent upon the dose and target organ(s).  Possible disorders include lung
cancer, anemia, leukemia, or bone cancer.

SKIN CONTACT:
QUARTZ:

ACUTE EXPOSURE - May cause irritation of intact skin via mechanical action.  Skin
abrasions may cause scarring.

CHRONIC EXPOSURE - No data available.

THORIUM PHOSPHATE:
RADIOACTIVE. See information on alpha radiation.

ALPHA RADIATION:
ACUTE EXPOSURE - Alpha radiation is not usually an external hazard as the large, highly
charged particles are not very penetrating.  However, absorption or penetration through
damaged skin may result in internal damage or deposition of radioactive materials.

CHRONIC EXPOSURE - Prolonged or repeated uptake my result in increased cancer risks.

EYE CONTACT
QUARTZ:

ACUTE EXPOSURE - May cause irritation via mechanical action. Particles of silica in the
range of 2-3 micrometers introduced into the corneal stroma of rabbit eyes caused very little
reaction.  These same  particles introduced into the anterior chamber resulted in an
inflammatory  reaction  in 3-5 weeks with  the formation  of  fibrotic nodules  in  the
iridocorneal angle. Finely divided silica injected into the vitreous of rabbit eyes has caused
necrosis of the retina and atrophy of the choroid.

CHRONIC EXPOSURE - An abnormally high silicon content in the cornea, and a gradual
decrease in visual acuity due to corneal opacities in the pupillary area, have been reported in
a group of foundry workers who developed pulmonary silicosis.

THORIUM PHOSPHATE:
RADIOACTIVE. See information on alpha radiation.

ALPHA RADIATION:
ACUTE EXPOSURE - Radiation affects the eye by inducing acute inflammation of the
conjunctiva and the cornea. The most sensitive part of the eye is the lens. An effect of eye
irradiation is cataract formation. Cataracts may begin to develop anywhere from 6 months
                            Page 13 of 17



                                      Revision Date: June 24, 2020
```

## Page 14

```text
to several years after a single, large exposure or after prolonged exposure.  The rate of
growth and the degree of opacity are dependent upon the dose of radiation. The silicon
content of these certified reference materials is expected to preclude any long-term eye
contact via irritation.

CHRONIC EXPOSURE - Repeated or prolonged exposure to alpha radiation may result in
cataract formation, as described above. Of the well-documented late effects of radiation on
man, leukemia and cataracts have been observed at doses lower than those producing skin
scarring and cancer or bone tumors. The lens of the eye is considered to be a critical organ
for exposure to radiation.   It is important to note that long-term eye contact with these
certified reference materials would most likely result in serious damage to the cornea long
before cataracts would be formed.

INGESTION:
QUARTZ:

ACUTE EXPOSURE - Effects of ingestion are due to mechanical action.  Crystalline
silicas are biologically inert.

CHRONIC EXPOSURE: No data available.

THORIUM PHOSPHATE:
RADIOACTIVE. See information on alpha radiation.

ALPHA RADIATION:
ACUTE EXPOSURE - The fate of ingested alpha emitters depends on their solubility and
valence.  Thorium dioxide is not soluble and the primary dose received would be to the
lining of the gut.

CHRONIC EXPOSURE - Repeated ingestion of alpha emitters may lead to increased
cancer risk.

RARE EARTH METALS:

Toxicology Studies Animals: The rare earth metals  (i.e. Yttrium, Cerium, Lanthanum,
Praseodymium, Neoddymium,  etc.) are moderately to highly toxic. The symptoms of
toxicity of the rare earth elements in animals include: writhing, ataxia, labored respirations,
walking on toes with arched back and sedation. There is a delayed lethality with death
peaking between 48 and 96 hours. A sex difference with males being less susceptible than
females is seen. If animals survive for 30 days these is generalized peritonitis, adhesions,
and hemorrhagic ascetic fluid and true granulomatous peritonitis and focal hepatic necrosis.
Chelating agents such as EDTA obscure the lethal effects of rare earths by either decreasing
their rate of release or by increasing their lethality by exchanging with other elements such
                            Page 14 of 17



                                      Revision Date: June 24, 2020
```

## Page 15

```text
     as calcium. The effects of atomic weight on lethality is difficult to assess, but the transition
     elements (terbium group) appear to have a lesser toxicity than those above or below them in
     the periodic table. The rare earth metals exhibit low toxicity via oral exposure. However,
     the intra-peritoneal route is highly toxic while the subcutaneous route has high to moderate
      toxicity. The production of skin and lung granulomas after exposure to them requires
     extensive protection to prevent such exposure. Toxicity from exposure to rare earth
     radionuclide is related to absorbed radiation dose.

    Toxicology Studies Humans: The characteristic oxidation state of rare earth elements is
     3+. Europium oxidizes readily, but the other rare earth elements react with oxygen in air
      at room temperature slowly. All of the rare earth metals ignite in  air  at elevated
     temperatures.  Since  the  rare  earth  metals  have  high  radiodensity,  some  of
    pneumoconioses reported are thought to be benign pneumoconioses. Cases were reported
    among workers exposed to cerium oxide and other lanthanoid metals in the glass
     manufacturing, lens polishing, and photoengraving industries. Findings have included
     small nodular lung opacities by chest  x-ray,  restrictive and obstructive defects by
     spirometry,  and  respiratory  tract  symptoms.  Unfortunately,  there  is  very   little
     histopathology data on these cases. The 14 lanthanide elements are associated with "rare
     earth pneumoconiosis," a condition most commonly reported among workers who were
    exposed to the fume from carbon arc lamps, and also reported in lens polishers and
    workers manufacturing cerium oxide polishing powder. The carbon arc lamp uses blends
     of lanthanide minerals as a metal core to stabilize the arc. With use of the carbon arc
    lamp, the carbon rod and metal core are eventually vaporized to form respirable fume and
     dust. Carbon arc lamps are used in movie projection, lithography, photoengraving, and
     floodlights. Respiratory symptoms in exposed workers were first reported in the 1930s. It
      is debated whether or not the stable lanthanides can cause pneumoconiosis. Some
     scientists believe that the lung disease is caused by radioactive contaminants such as
    thorium-238 and cerium-44. Recent animal studies support the view that the stable
     lanthanide elements can cause granulomatous and fibrotic lesions in the lungs.


SECTION 12: ECOLOGICAL INFORMATION

    Environmental Impact Rating (0-4): No data available

    Acute Aquatic Toxicity: No data available

     Degradability: No data available

    Log Bioconcentration Factor (BCF): No data available

    Log Octanol/water partition coefficient: No data available
                                 Page 15 of 17



                                            Revision Date: June 24, 2020
```

## Page 16

```text
SECTION 13: DISPOSAL INFORMATION

    Observe all Federal, State and local Regulations when disposing of this substance.


SECTION 14: TRANSPORTATION INFORMATION

    The U.S. Department of Transportation (D.O.T.) Code of Federal Regulations (49 CFR
     Parts 100-185), the International Air Transportation Association (IATA), International
     Civil Aviation Organization (ICAO) and International Maritime Organization (IMDG)
     are all factored into the classification and transport of material.

     Proper Shipping Name:
    Hazard Class:
    UN/ID Number:          To be determined on a case by case basis.
     Special Information:
    Packing Group:

     Classification of substances with multiple hazards must be determined in accordance with
     the criteria presented in the above mentioned regulations. Due to the various
     quantities/combinations of materials being shipped at one time, the information above
    must be determined based on the characteristics of the specific shipment.


SECTION 15: REGULATORY INFORMATION
   TSCA STATUS: Y

   CERCLA SECTION 103 (40 CFR 302.4):      N
   SARA SECTION 302 (40 CFR 355.30):       N
   SARA SECTION 304 (40 CFR 355.40):       N
   SARA SECTION 313 (40 CFR 372.65):       Y
   OSHA PROCESS SAFETY (29 CFR 1910.119):  N
   CALIFORNIA PROPOSITION 65:          Y

   SARA HAZARD CATEGORIES, SARA SECTIONS 311/312 (40 CFR 370.21)

   ACUTE HAZARD:          Y
   CHRONIC HAZARD:        Y
    FIRE HAZARD:           N
                                 Page 16 of 17



                                            Revision Date: June 24, 2020
```

## Page 17

```text
   REACTIVITY HAZARD:      N
   SUDDEN RELEASE HAZARD:   N

SECTION 16: OTHER INFORMATION

     This material is prepared for use as a standard or in inter-laboratory comparison programs at
     analytical laboratories, which routinely handle thorium, uranium and/or plutonium.  The
     material 82Th1448 is a stock of ore material stored at NBL but has not been prepared for
    any specific use. The New Brunswick Laboratory (NBL) assumes that recipients of this
     material have developed  internal  safety  procedures, which guard  against  accidental
     exposure to radioactive and toxic materials, contamination of the laboratory environment, or
      criticality. NBL further expects that personnel who handle radioactive materials have been
     thoroughly trained in the safety procedures developed by and for their Laboratory.

    The information and recommendations set forth herein are presented in good faith and
     believed to be correct as of the revision date. However, recipients of this material should
     use this information only as a supplement to other information gathered by them, and
     should make independent judgment of the suitability and accuracy of this information. This
     statement is not intended to provide comprehensive instruction in developing an appropriate
     safety program and does not include all regulatory guidelines.

     This information  is furnished without warranty, and any use of the product not in
    conformance with this Safety Data Sheet, or in combination with any other product or
     process, is the responsibility of the user.





                                 Page 17 of 17



                                            Revision Date: June 24, 2020
```
